Healio (7/23, Gramigna) reported, “The continued use of electroconvulsive therapy [ECT] appeared warranted for reducing suicide risk among patients with severe depression,” investigators concluded after analyzing “data from Swedish national registers of 28,557 patients (ECT group mean age, 55.9 years; non-ECT group, 45.2 years; 55.5% women) who received inpatient care between Jan. 1, 2012, and Oct. 31, 2018, for moderate depression, severe depression or severe depression with psychosis.” The findings of the “registry-based cohort study” were published online July 21 in JAMA Network Open. (SOURCE: APA Headlines)